JPRN-UMIN000009357已完成未知
The efficacy and safety of long-acting muscarinic antagonist (LAMA) and long-acting beta2-agonist (LABA) in COPD patients with benign prostatic hyperplasia (BPH) - The efficacy and safety of LAMA and LABA in COPD with BPH
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •History of hyper-sensitivity to long-acting muscarinic antagonist (LAMA), long-acting beta2-agonist (LABA), inhaled corticosteroid (ICS) Patients with bronchial asthma Patients during acute exacerbation Presence of infectious disease, pneumothorax, and severe heart failure
研究者
相似试验
尚未招募
不适用
Efficacy of long-acting muscarinic antagonist for chronic coughchronic coughJPRN-UMIN000023773Kyoto University60
招募中
2 期
Comparison of efficacy between long-acting muscarinic antagonist (LAMA) and leukotriene receptor antagonist (LTRA) as step-up treatment in patients with uncontrolled bronchial asthmaBronchial asthmaJPRN-UMIN000022696Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine200
尚未招募
4 期
Evaluate the efficacy and safety of Artesunate-mefloquine (ASMQ) and low dose primaquine to treat uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Champasack province, Lao PDRMalariaACTRN12618001349235Ministry of Health120
已完成
不适用
Persistence rate with medical treatment in patients with idiopathic or neurogenic overactive bladderOveractive bladderUrological and Genital DiseasesOther specified disorders of bladderISRCTN13129226Erasmus Medical Center123
暂停
4 期
Efficacy and safety of artesunate-mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in Binh Phuoc and Dak Nong provinces, Viet Nam, in 2019.Patients infected Plasmodium falciparum malaria.Infection - Other infectious diseasesACTRN12620001375943World Health Organization84